The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the production of Chloroquine for clinical trials in the search for a cure for COVID-19.
Director-General of the agency, Mojisola Adeyeye, made the announcement on Friday at the NAFDAC headquarters in Lagos.
She, however, pointed out that NAFDAC is not approving Chloroquine for the treatment of COVID-19 but for clinical trials to find treatment for the virus.
“NAFDAC is not approving Chloroquine as a product that has can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.
“Therefore the medicine is being approved just for the clinical trials,” Adeyeye said.
She, therefore, called on experts and researchers that are interested in doing a clinical trial on Chloroquine to approach approved outlets.
“Right now, we have asked one company to make a batch of Chloroquine for the purpose of clinical trial,” Adeyeye added.
Post Views: 8
You may be interested
Buhari’s Lopsided Appointments Worsening Nigeria’s Division – Governor OrtomWebby - September 24, 2021
Ortom and Buhari Governor Samuel Ortom has blamed President Muhammadu Buhari for inciting people to break away from Nigeria. The…
Policemen Rape Three Students, Abia Poly Students Protest (Photos)Webby - September 24, 2021
Abia Polytechnic students protesting Academic activities were brought to a halt by protesting students of Abia State Polytechnic, Aba on…
Hosting FFK At Aso Villa Evidence Of Buhari’s Capacity To Forgive – Femi AdesinaWebby - September 24, 2021
Femi Adesina, the Special Adviser to the President, Muhammadu Buhari on Media and Publicity, has explained why his principal hosted an…